Ellington Management Group’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-10,600
Closed -$286K 672
2018
Q2
$286K Buy
+10,600
New +$281K 0.02% 292
2016
Q3
Sell
-17,700
Closed -$335K 696
2016
Q2
$335K Buy
+17,700
New +$370K 0.47% 32
2015
Q3
Sell
-22,398
Closed -$670K 891
2015
Q2
$670K Buy
+22,398
New +$631K 0.16% 168
2014
Q3
Sell
-9,500
Closed -$262K 462
2014
Q2
$262K Sell
9,500
-7,100
-43% -$194K 0.12% 275
2014
Q1
$486K Buy
+16,600
New +$445K 0.14% 224
2013
Q3
Sell
-17,900
Closed -$377K 965
2013
Q2
$377K Buy
+17,900
New +$386K 0.07% 420

Other funds holding TBI

Ellington Management Group's TBI Position: Q3 2018 in Review

Ellington Management Group sold out of Trueblue (TBI) in Q3 2018, closing a stake of 10,600 shares — an estimated $286K sold.

Ellington Management Group first reported a position in TBI in Q2 2013 and held it in 6 quarters. The position peaked at $670K in Q2 2015. 183 funds tracked by Wall St. Rank hold TBI as of Q3 2018.

  • Ellington Management Group reported no remaining Trueblue position as of Q3 2018 after selling out during the quarter.
  • Ellington Management Group sold 10,600 Trueblue shares in Q3 2018, an estimated $286K.
  • Ellington Management Group first reported a position in Trueblue in Q2 2013 and held it in 6 quarters.
  • Ellington Management Group's Trueblue position peaked at $670K in Q2 2015.
  • 183 funds tracked by Wall St. Rank held Trueblue as of Q3 2018.

Based on Ellington Management Group's 13F filing for Q3 2018, filed 14 Nov 2018.